BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · IEX Real-Time Price · USD
10.51
+0.22 (2.14%)
Apr 19, 2024, 4:00 PM EDT - Market closed

BTSG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
8,8267,7216,6985,5804,5252,536
Revenue Growth (YoY)
14.32%15.27%20.03%23.32%78.44%-
Cost of Revenue
7,3926,3665,4504,5323,6912,160
Gross Profit
1,4341,3541,2481,049833.91375.91
Selling, General & Admin
1,2871,1261,014883.55770.59312.13
Other Operating Expenses
040.860000
Operating Expenses
1,2871,1661,014883.55770.59312.13
Operating Income
147.18187.83234.18165.1963.3163.78
Interest Expense / Income
324.59233.58165.32138.95166.8974.61
Other Expense / Income
-2.23-0.311.460.341.29-
Pretax Income
-175.18-45.4467.425.9-104.87-10.83
Income Tax
-20.588.4717.65.09-32.49-3.21
Net Income
-154.6-53.9149.820.81-72.38-7.62
Net Income Growth
--139.30%---
Shares Outstanding (Basic)
11811811811711176
Shares Outstanding (Diluted)
11811812211811176
Shares Change
0.02%-3.24%3.53%6.19%45.55%-
EPS (Basic)
-1.31-0.460.420.18-0.65-0.10
EPS (Diluted)
-1.31-0.460.410.18-0.65-0.10
EPS Growth
--127.78%---
Free Cash Flow
137.26-74.77210.9170.7359.6943.25
Free Cash Flow Per Share
1.16-0.631.791.460.540.57
Gross Margin
16.24%17.54%18.64%18.79%18.43%14.82%
Operating Margin
1.67%2.43%3.50%2.96%1.40%2.51%
Profit Margin
-1.75%-0.70%0.74%0.37%-1.60%-0.30%
Free Cash Flow Margin
1.56%-0.97%3.15%3.06%1.32%1.71%
Effective Tax Rate
--26.11%19.64%--
EBITDA
351.75392.11431.88346.35216.89144.95
EBITDA Margin
3.99%5.08%6.45%6.21%4.79%5.72%
Depreciation & Amortization
202.34203.97199.16181.5154.8781.17
EBIT
149.41188.14232.72164.8562.0263.78
EBIT Margin
1.69%2.44%3.47%2.95%1.37%2.51%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).